Chinese genome sequencing firm BGI, previously know as the Beijing Genomics Institute, has led a RMB200 million (US$30 million) series A funding round in Beijing Gene+ Technology, a gene testing and precision medicine start-up, according to Chinese media reports.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription?